Eva Forssell‐Aronsson

Specific Growth Rate versus Doubling Time for Quantitative Characterization of Tumor Growth Rate

Esmaeil Mehrara, Eva Forssell‐Aronsson, Håkan Ahlman et al. · Cancer Research · 2007 · 237 citations

Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens

Peter Larsson, Hanna Engqvist, Jana Biermann et al. · Scientific Reports · 2020 · 209 citations · Full text

A Transplantable Human Carcinoid as Model for Somatostatin Receptor-Mediated and Amine Transporter-Mediated Radionuclide Uptake

Lars Kölby, Peter Bernhardt, Håkan Ahlman et al. · American Journal Of Pathology · 2001 · 118 citations · Full text

Oncogenic Agent, Medicine, Radionuclide Therapy +10

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours

Ola Nilsson, Lars Kölby, Bo Wängberg et al. · British Journal of Cancer · 1998 · 109 citations · Full text

Somatic Variant, Endocrine-related Cancer, Somatostatin Receptor Subtypes +9

Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment

Johanna Svensson, Gertrud E. B. Berg, Bo Wängberg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 108 citations · Full text